Telephone +44 (0)845 299 3935

Fax +44 (0)1204 441 363

Enquiries enquiries@zerenex-molecular.com

Sales sales@zerenex-molecular.com

Get in touch

Top of page

Industry News

US regulators will undertake a speedy review of Bristol-Myers Squibb’s application to expand use of its immunotherapy Opdivo to include...
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us